Elanco Animal Health Incorporated (ELAN)

Elanco Animal Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	4,417	4,411	4,764	3,271	3,071
Revenue Growth (YoY)	0.14%	-7.41%	45.64%	6.51%	0.14%
Cost of Revenue	1,931	1,913	2,132	1,667	1,470
Gross Profit	2,486	2,498	2,632	1,604	1,601
Selling, General & Admin	1,285	1,265	1,403	997	760
Research & Development	327	321	369	329	270
Other Operating Expenses	1,792	743	1,195	805	414
Operating Expenses	3,404	2,329	2,967	2,131	1,444
Operating Income	-918	169	-335	-527	157
Interest Expense / Income	277	241	236	150	79
Pretax Income	-1,195	-72	-571	-677	78
Income Tax	36	6	-88	-103	10
Net Income	-1,231	-78	-483	-574	68
Net Income Growth	-	-	-	-	-21.39%
Shares Outstanding (Basic)	492	488	487	441	369
Shares Outstanding (Diluted)	492	488	487	441	370
Shares Change	0.82%	0.23%	10.38%	19.20%	18.04%
EPS (Basic)	-2.50	-0.16	-0.99	-1.30	0.18
EPS (Diluted)	-2.50	-0.16	-0.99	-1.30	0.18
EPS Growth	-	-	-	-	-35.71%
Free Cash Flow	131	281	324	-280	27
Free Cash Flow Per Share	0.27	0.57	0.67	-0.63	0.07
Gross Margin	56.28%	56.63%	55.25%	49.04%	52.13%
Operating Margin	-20.78%	3.83%	-7.03%	-16.11%	5.11%
Profit Margin	-27.87%	-1.77%	-10.14%	-17.55%	2.21%
Free Cash Flow Margin	2.97%	6.37%	6.80%	-8.56%	0.88%
Effective Tax Rate	-	-	-	-	12.82%
EBITDA	-224	851	381	-10	471
EBITDA Margin	-5.07%	19.29%	8.00%	-0.31%	15.34%
Depreciation & Amortization	694	682	716	517	314
EBIT	-918	169	-335	-527	157
EBIT Margin	-20.78%	3.83%	-7.03%	-16.11%	5.11%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).